BioElectronics, in pulsed therapy deal:
This article was originally published in Clinica
BioElectronics (Frederick, Maryland) has signed an agreement with Barron Medical, a distributor of medical equipment headquartered in Chino Hills, California, to distribute its ActiPatch electromagnetic therapy technology in the US. The two companies will combine to bring the drug-free anti-inflammatory patch to a market of 200 million soft tissue injuries in the US every year. The product administers "weeks of continuous pulsed therapy for less than a dollar a day", claims BioElectronics.
You may also be interested in...
Hyloris Lines Up Hectic Year Of Clinical Trials And Major US Launch
Hyloris has an eventful year ahead as it plans to conduct numerous trials for products in its ever-expanding pipeline and launch Maxigesic IV in the US.
AAM Departures Lead To Change Of Chair For IGBA
The AAM has confirmed the departure of three executives, one of whom had also been serving as chair of the IGBA. As a result, the global generics industry association has brought in a new interim chair, at the same time as the head of one of the industry’s largest players has joined its CEO Advisory Committee.
Ukraine’s Plea To Industry: Restart Clinical Trials And Give Us New ‘Weapons’ To Fight Cancer
More than one year into the conflict, pharma employees in Ukraine have made heroic efforts to maintain existing clinical studies – but what the country’s doctors and CROs really want is for international companies to start opening new trials again.